Jiao Da Onlly has recently released its performance forecast, projecting a revenue of RMB 315 million for the year 2025. This figure highlights the company’s phased achievements in business transformation and industrial optimization in the post-pandemic era. As an enterprise focused on the health industry, Jiao Da Onlly has been concentrating on sectors such as health products, medical services, and elderly care in recent years, gradually enhancing its market competitiveness through product innovation and channel expansion. The revenue target attainment can be attributed to both the growing demand in the broader health industry—particularly the increased consumer attention on health management products—and the initial success of the company’s strategic adjustments, especially in digital marketing and integrated online-to-offline service models. Moving forward, the company is likely to further deepen its dual-drive strategy of research and market development, balancing profitability with long-term growth, though it must still address challenges such as intensifying industry competition and cost control.
交大昂立近日发布业绩预告，预计2025年实现营业收入3.15亿元。这一数据反映出公司在后疫情时代稳步推进业务转型与产业优化的阶段性成果。作为一家以健康产业为核心的企业，交大昂立近年来聚焦保健品、医疗服务和养老等领域，通过产品创新与渠道拓展逐步提升市场竞争力。营收目标的实现，一方面得益于大健康行业整体需求增长，特别是消费者对健康管理产品的关注度提升；另一方面也显示出公司战略调整初显成效，尤其在数字化营销与线上线下融合服务模式上的投入逐步兑现。未来，公司或将继续深化科研与市场双轮驱动，平衡盈利能力与长期发展，但其仍需应对行业竞争加剧及成本管控等挑战。
原创文章，作者：admin，如若转载，请注明出处：https://avine.cn/22864.html